DNA Methylation
Medicine & Life Sciences
100%
Fatty Liver
Medicine & Life Sciences
43%
Genome
Medicine & Life Sciences
32%
CpG Islands
Medicine & Life Sciences
28%
Renal Cell Carcinoma
Medicine & Life Sciences
24%
Hepatocellular Carcinoma
Medicine & Life Sciences
24%
Methylation
Medicine & Life Sciences
20%
Genes
Medicine & Life Sciences
19%
Tsuda, N. ,
Tian, Y. ,
Fujimoto, M. ,
Kuramoto, J. ,
Makiuchi, S. ,
Ojima, H. ,
Gotoh, M. ,
Hiraoka, N. ,
Yoshida, T. ,
Kanai, Y. &
Arai, E. ,
2023 7月 ,
In: Journal of Cancer Research and Clinical Oncology. 149 ,
8 ,
p. 5109-5125 17 p. 研究成果: Article › 査読
Fatty Liver
100%
DNA Methylation
92%
Hepatocellular Carcinoma
75%
Genes
37%
Cluster Analysis
20%
Hirano, T. ,
Arai, E. ,
Fujimoto, M. ,
Nakayama, Y. ,
Tian, Y. ,
Ito, N. ,
Makabe, T. ,
Yamagami, W. ,
Susumu, N. ,
Aoki, D. &
Kanai, Y. ,
2022 11月 ,
In: Journal of gynecologic oncology. 33 ,
6 , e74.
研究成果: Article › 査読
Endometrial Neoplasms
100%
DNA Methylation
96%
Genome
66%
Formaldehyde
25%
Paraffin
25%
Kuramoto, J. ,
Arai, E. ,
Fujimoto, M. ,
Tian, Y. ,
Yamada, Y. ,
Yotani, T. ,
Makiuchi, S. ,
Tsuda, N. ,
Ojima, H. ,
Fukai, M. ,
Seki, Y. ,
Kasama, K. ,
Funahashi, N. ,
Udagawa, H. ,
Nammo, T. ,
Yasuda, K. ,
Taketomi, A. ,
Kanto, T. &
Kanai, Y. ,
2022 12月 ,
In: Clinical Epigenetics. 14 ,
1 , 168.
研究成果: Article › 査読
Fatty Liver
100%
DNA Methylation
92%
Hepatocellular Carcinoma
35%
Liver
22%
High Pressure Liquid Chromatography
13%
Hamada, K. ,
Tian, Y. ,
Fujimoto, M. ,
Takahashi, Y. ,
Kohno, T. ,
Tsuta, K. ,
Watanabe, S. I. ,
Yoshida, T. ,
Asamura, H. ,
Kanai, Y. &
Arai, E. ,
2021 2月 1 ,
In: Carcinogenesis. 42 ,
2 ,
p. 169-179 11 p. 研究成果: Article › 査読
Adenocarcinoma of Lung
100%
DNA Methylation
92%
DNA
52%
Genes
37%
Mutation
34%
Tian, Y. ,
Arai, E. ,
Makiuchi, S. ,
Tsuda, N. ,
Kuramoto, J. ,
Ohara, K. ,
Takahashi, Y. ,
Ito, N. ,
Ojima, H. ,
Hiraoka, N. ,
Gotoh, M. ,
Yoshida, T. &
Kanai, Y. ,
2020 10月 1 ,
In: Journal of Cancer Research and Clinical Oncology. 146 ,
10 ,
p. 2461-2477 17 p. 研究成果: Article › 査読
Fatty Liver
100%
DNA Methylation
92%
Hepatocellular Carcinoma
75%
Gene Expression
56%
Messenger RNA
26%